Heartflow, Inc. Common Stock
HTFL$30.51 +1.53 (5.34%)
Company News
AHA 2025: Late-Breaking Data Reinforce the Prognostic Power of AI-Driven Heartflow Plaque Analysis as the Most Clinically Validated Framework for Coronary Risk Stratification
Heartflow presented late-breaking data at AHA 2025 demonstrating that total plaque volume can predict cardiovascular events with high accuracy, showing patients in the highest plaque volume stage have over 5x greater risk of major cardiovascular events.
